Average years of potential life lost in those who have died from brain and CNS tumors in the USA

Neuroepidemiology

Volumn 27, Issue 1, 2006, Pages 22-27

  Thuppal, Shalini ^a   Propp, Jennifer M ^a   McCarthy, Bridget J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Average years of potential life lost; Brain tumors; Central nervous system tumors, mortality

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CALCULATION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DEATH; ETHNOLOGY; FEMALE; GENDER; HEALTH STATISTICS; HISPANIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; RACE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; UNITED STATES;

EID: 33746329877     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093896     Document Type: Article

References (18)

1. Surveillance, Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2002). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission.
2. Central Brain Tumor Registry of the United States: Statistical report: primary brain tumors in the United States, 1997-2001. Central Brain Tumor Registry of the United States, 2004.
3. Central Brain Tumor Registry of the United States: CBTRUS special analysis. Central Brain Tumor Registry of the United States, March 2006.
4. Premature mortality in the United States: public health issues in the use of years of potential life lost. Morbid Mortal Wkly Rep 1986;35(suppl 2):S1-S11.
5. Burnet NG, Jefferies SJ, Benson RJ, Hunt DP, Treasure FP: Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds. Br J Cancer 2005;92:241-245.
6. Aoun S, Pennebaker D, Pascal R: To what extent is health and medical research funding associated with the burden of disease in Australia? Aust NZ J Public Health 2004;28:80-86.
7. Bonneux L: How to measure the burden of mortality? J Epidemiol Community Health 2002;56:128-131.
8. Gardner JW, Sanborn JS: Years of potential life lost (YPLL) - What does it measure? Epidemiology 1990;1:322-329.
9. Gross CP, Anderson GF, Powe NR: The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999;340:1881-1887.
10. Horm JW, Sondik EJ: Person-years of life lost due to cancer in the United States, 1970 and 1984. Am J Public Health 1989;79:1490-1493.
11. Indrayan A, Wysocki MJ, Kumar R, Chawla A, Singh N: Estimates of the years-of-life-lost due to the top nine causes of death in rural areas of major states in India in 1995. Natl Med J India 2002;15:7-13.
12. Lam LT: Different quantitative measures of the impact of premature deaths on the community in Australia. Aust NZ J Public Health 2004;28:555-558.
13. Mariotti S, D'Errigo P, Mastroeni S, Freeman K: Years of life lost due to premature mortality in Italy. Eur J Epidemiol 2003;18:513-521.
14. Murray CJL: Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994;72:429-445.
15. Yoon SJ, Lee H, Shin Y, Kim YI, Kim CY, Chang H: Estimation of the burden of major cancers in Korea. J Korean Med Sci 2002;17:604-610.
16. Chang D: Statistics on incidence, survival rates and mortality associated with brain tumors in Australia. National Cancer Statistics Clearing House, Australian Institute of Health and Welfare, 2003.
17. Blomqvist P, Lycke J, Strang P, Tornqvist H, Ekbom A: Brain tumours in Sweden 1996: care and costs. J Neurol Neurosurg Psychiatry 2000;69:792-798.
18. Clark LT, Ferdinand KC, Flack JM, Gavin JR 3rd, Hall WD, Kumanyika SK, et al: Coronary heart disease in African Americans. Heart Dis 2001;3:97-108.